Connect Biopharma Holdings Limited Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets
Connect Biopharma Holdings Limited (CNTB) reported Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets of $1.84 million for the 6-month period ending 2024-06-30, per its 6-K filed 2024-09-05.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets · last filed 2024-09-05
CNY
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 6 month | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|---|
| 2023-06-30 | 16.07M CNY 6-K · filed 2023-09-12 | |
| 2022-12-31 | 45.60M CNY 20-F · filed 2023-04-11 | |
| 2022-06-30 | 27.89M CNY 6-K · filed 2023-09-12 | |
| 2021-12-31 | 57.86M CNY 20-F · filed 2023-04-11 | |
| 2021-06-30 | 19.42M CNY 6-K · filed 2022-09-13 | |
| 2020-12-31 | 25.19M CNY 20-F · filed 2023-04-11 | |
| 2019-12-31 | 3.88M CNY 20-F · filed 2022-03-31 |
USD
| Period end | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 6 month | Expense From Share-based Payment Transactions In Which Goods Or Services Received Did Not Qualify For Recognition As Assets 12 month |
|---|---|---|
| 2024-06-30 | $1.84M 6-K · filed 2024-09-05 | |
| 2023-12-31 | $3.26M 20-F · filed 2024-04-16 | |
| 2023-06-30 | $2.30M 6-K · filed 2024-09-05 | |
| 2022-12-31 | $6.91M 20-F · filed 2024-04-16 | |
| 2021-12-31 | $8.99M 20-F · filed 2024-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |